Skye Bioscience’s $125 Million Merger with Redx Pharma Creates Fibrx Therapeutics—Funding Operations Through Key Clinical Trials
Market Chameleon (Mon, 17-Aug 10:30 AM)
Skye Bioscience and Redx Pharma Combine to Create Fibrx with $125 Million Financing—Ownership, Leadership, and Pipeline in Focus
Market Chameleon (Fri, 14-Aug 10:32 AM)
